{"url_path":"/sec/tenx/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/34956/0001193125-26-293485-index.html","accession_number":"0001193125-26-293485","cik":"0000034956","ticker":"TENX","issuer_name":"TENAX THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/34956/0001193125-26-293485-index.html","primary_entity_key":"0000034956","primary_entity_name":"TENAX THERAPEUTICS, INC."},"word_count":82,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit 99.1\n  \n[Press release dated July 2, 2026.](d20457dex991.htm)\n\nExhibit 104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: July 2, 2026\n \nTENAX THERAPEUTICS, INC.\n\n \n\n \nBy:\n \n\n/s/ Christopher T. Giordano\n\n \n\n \nName:\n \nChristopher T. Giordano\n\n \n\n \nTitle:\n \nPresident and Chief Executive Officer"}